Cancer Therapy Resistance: Choosing Kinase Inhibitors

Carmela Dell’Aversana; Federica Sarno; Rosaria Benedetti; Wouter Leonard Megchelenbrink; Donato Cappetta

doi:10.3390/pharmaceutics16030373

Pharmaceutics (Mar 2024)

Cancer Therapy Resistance: Choosing Kinase Inhibitors

Carmela Dell’Aversana,
Federica Sarno,
Rosaria Benedetti,
Wouter Leonard Megchelenbrink,
Donato Cappetta

Affiliations

Carmela Dell’Aversana: Institute of Experimental Endocrinology and Oncology “Gaetano Salvatore” (IEOS)-National Research Council (CNR), 80131 Napoli, Italy
Federica Sarno: Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Rosaria Benedetti: Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Wouter Leonard Megchelenbrink: Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
Donato Cappetta: Division of Pharmacology, Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy

DOI: https://doi.org/10.3390/pharmaceutics16030373
Journal volume & issue: Vol. 16, no. 3
p. 373

Abstract

Read online

Recent advances in comprehending the essential molecular mechanisms that govern cancer signaling have revealed the pivotal involvement of kinases in the development and progression of various cancer types [...]

n/a

Published in Pharmaceutics

ISSN: 1999-4923 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pharmacy and materia medica
Website: http://www.mdpi.com/journal/pharmaceutics/

About the journal

Abstract

Keywords